Nuclera

Provider of rapid protein expression and screening systems for biotechnology labs

placeCambridge, England, United Kingdom calendar_todayFounded 2013 groups26 employees language nuclera.com

Registered entities

Social engagement

Social engagement: 25.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

35 investors on record; lead investors include RT Partners, Elevage Medical Technologies, Elevage Medical Technologies.

Investor typeCountShare
Venture capital1337%
Private equity39%
Bank & private debt13%
Other / undisclosed1851%

Hiring activity

Hires periodically

4 roles tracked across 3 of the last 12 months

21 Jun 2026 · Customer Service Specialist · Cambridge, England

7 Apr 2026 · Product Manager - Antibody Applications · Billerica

2 Dec 2025 · Production Technician · Billerica

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Event
Webinar on integrating actionable screening data into your project planning
25 Jun 2026
Event
Drug DiscoveryTM benchmarking data proving translatability between Nuclera's eProtein DiscoveryTM system and larger scale E. coli production
24 Jun 2026
Event
Cell-free screening for AI antibody discovery pipelines
Coming soon